| Translated title of the contribution | No evidence of safety concerns other than the known side effects: Tocilizumab seems safe to use in COVID-19 |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 22-24 |
| Number of pages | 3 |
| Journal | Pharmaceutisch weekblad |
| Volume | 156 |
| Issue number | 23 |
| Publication status | Published - 11 Jun 2021 |
| Externally published | Yes |
Tocilizumab lijkt veilig toepasbaar bij COVID-19
- Fenna Poppelaars
- , Jette van Lint
- , Harald Vonkeman
- , Heieen van der Sijs
- , Juliëtte Zwaveling
- , Marieke Kerskes
- , Arthur van Zanten
- , Naomi Jessurun
Research output: Contribution to journal › Article › Academic › peer-review